fast neutron radiotherapy united states entering new era dedicated generators isocentric beam capability replacing treatment facilities based fixed beams extracted physics accelerators available clinical data come older facilities majority randomized trials conducted used neutrons mixed schedule photons aim deliver total dose neutrons neutron dose fraction set estimated equivalent NUMBER gy photons terms late normal tissue injury overall treatment time held constant compared control photon therapy regimens usually weeks random studies type showed evidence therapeutic gain treatment advanced primary carcinomas head neck lung uterine cervix pancreas statistically significant benefit favor mixed schedule presently apparent local control survival patients advanced prostate cancer clearance neck nodes patients advanced squamous carcinoma head neck based encouraging results pilot study mixed scheduled irradiation preoperatively bladder cancer random study begun NUMBER cases accrued analysis randomized trials comparing protracted neutron regimens photon therapy conducted negative lung pancreatic cancer suggestion therapeutic gain small patient numbers observed treatment inoperable salivary gland tumors advanced squamous carcinomas head neck large randomized studies various neutron doses delivered boost high grade astrocytomas concurrently photon irradiation failed define therapeutic window tumor destruction brain necrosis based reassessment available clinical radiobiological data taking advantage greater technical flexibility offered facilities strategy fast neutron therapy future trials changed trials neutrons used fraction week regimen treat gross disease elective therapy given possible using low let irradiation concomitantly research proceeding define predictors tumor response high let radiations order better select patients fast neutron radiotherapy hospital based fifths hospital based